We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Measurement of Omega-3 Fatty Acids More Reliable in Red Blood Cells Than in Plasma

By LabMedica International staff writers
Posted on 17 Jul 2013
Print article
Findings released in a recently published study showed that omega-3 fatty acid levels in red blood cells were less susceptible to dietary influences and, therefore, represented a better matrix for its measurement than did plasma.

Investigators at Health Diagnostic Laboratory, Inc. (Richmond, VA, USA) compared the affect of dietary fish oil and fish oil supplements on measurement of blood omega-3 fatty acid levels in a study population comprising 20 healthy volunteers.

The volunteers were given four capsules containing 3.6 grams of omega-3 fatty acids alongside a standard breakfast. Blood samples were drawn six times over the course of 24 hours, and the investigators monitored eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) levels in plasma and red blood cells. At six hours after capsule intake, the plasma concentration of EPA and DHA had increased by 47%, while the plasma EPA and DHA percentage of total fatty acids increased by 19%. In contrast, levels of EPA and DHA in red blood cells did not change from baseline values. By 24 hours after capsule intake, plasma EPA and DHA levels were 10-fold greater than those in red blood cells.

"Although some experts question the value of omega-3 fatty acid supplementation for reducing risk of coronary heart disease, medical testing for omega-3 fatty acid status has become more common and clinicians have a choice of whether to use red blood cell or plasma-based assays," said senior author Dr. William S. Harris, a senior research scientist at Health Diagnostic Laboratory, Inc. "While different assays have different performance characteristics, fasting requirements, and sensitivities, it is important for clinicians to choose the appropriate testing method. This research backs our hypothesis that the red blood cell omega-3 assay is the preferred sample type for the assessment of fatty acids in the body."

The study was published in the May 9, 2013, online edition of the Journal of Clinical Lipidology.

Related Links:
Health Diagnostic Laboratory, Inc.

Gold Supplier
PCR Microplate
Auto Immunochemistry System
IFA Automation Solution
dIFine 30 System

Print article



view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more


view channel
Image: Newly observed anti-FSP antibodies have also been found to predict immune-related adverse events (Photo courtesy of Calviri)

First Blood-Based Biomarkers Test to Predict Treatment Response in Cancer Patients

Every year worldwide, lung cancer afflicts over two million individuals and almost the same number of people succumb to the disease. This malignancy leads the charts in cancer-related mortalities, with... Read more


view channel
Image: The rapid MTB strip test for tuberculosis can identify TB patients within two hours (Photo courtesy of Chulalongkorn University)

Rapid MTB Strip Test Detects Tuberculosis in Less Than an Hour without Special Tools

Tuberculosis (TB), a highly infectious disease, continues to pose significant challenges to public health worldwide. TB is caused by a bacterium known as "Mycobacterium tuberculosis," spreading through... Read more


view channel
Image: The UNIQO 160 (CE-IVDR) advances diagnostic analysis for autoimmune diseases (Photo courtesy of EUROIMMUN)

Novel Automated IIFT System Enables Cutting-Edge Diagnostic Analysis

A newly-launched automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics offers an all-in-one solution to enhance the efficiency of the complete IIFT process, comprising... Read more


view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more


view channel
Image: The Coris acquisition provides Avacta with a broad, professional-use rapid test product portfolio (Photo courtesy of Coris Bioconcept)

Avacta Expands Diagnostics Portfolio with Acquisition of Rapid Test Maker Coris Bioconcept

Avacta Group plc (London, UK), a life sciences company developing oncology drugs and diagnostics, has acquired Coris Bioconcept SRL (Gembloux, Belgium) for an upfront cash consideration of GBP 7.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.